drugset / Trial / NCT01718210

Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure

NCT01718210

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether in Assisted Reproductive Technologies the use of culture medium supplemented with GM-CSF, a growth factor working on stem cells, may improve the embryo implantation in patients experiencing recurrent implantation failure in IVF cycles.

Timeline

Start
2012-12
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject sargramostim Protein / enzyme biologic

Indications